Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union. It offers Ortho-ACI, a cartilage cell therapy for treatment of articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; Remplir, a collagen scaffold used in peripheral nerve repair. The company’s product pipeline includes Collagen Medical Device Platform, a product for nerve, tendon and ligament repair; Tendon Cell Therapy for totator cuff that is in Phase II of clinical trial and for Lateral epicondyle that is in Phase III of clinical trial. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
तुलना करने के लिए मीट्रिक्स | OCC | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधOCCपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −28.8x | −8.9x | −0.5x | |
PEG अनुपात | 4.38 | −0.29 | 0.00 | |
क़ीमत/बुक | 16.9x | 6.2x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 32.7x | 16.2x | 3.3x | |
अपसाइड (विश्लेषक लक्ष्य) | 46.2% | 136.7% | 45.6% | |
उचित मूल्य अपसाइड | अनलॉक करें | 11.9% | 5.8% | अनलॉक करें |